Vitamin Shoppe, Inc (VSI) Director John D. Bowlin Acquires 40,000 Shares of Stock
Vitamin Shoppe, Inc (NYSE:VSI) Director John D. Bowlin acquired 40,000 shares of the business’s stock in a transaction on Friday, August 25th. The shares were bought at an average price of $5.50 per share, for a total transaction of $220,000.00. Following the acquisition, the director now owns 56,028 shares in the company, valued at approximately $308,154. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Vitamin Shoppe, Inc (NYSE VSI) opened at 5.00 on Wednesday. The stock’s 50 day moving average price is $8.98 and its 200-day moving average price is $14.78. Vitamin Shoppe, Inc has a 52-week low of $4.95 and a 52-week high of $28.41. The firm’s market cap is $116.12 million.
Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing analysts’ consensus estimates of $0.39 by $0.16. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The company had revenue of $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. During the same period in the prior year, the firm earned $0.55 earnings per share. The business’s revenue for the quarter was down 8.4% compared to the same quarter last year. On average, analysts forecast that Vitamin Shoppe, Inc will post $0.79 EPS for the current year.
Hedge funds have recently modified their holdings of the company. Point72 Asset Management L.P. bought a new stake in shares of Vitamin Shoppe during the first quarter worth approximately $11,515,000. FMR LLC boosted its stake in shares of Vitamin Shoppe by 32.4% in the second quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock worth $14,617,000 after buying an additional 307,050 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Vitamin Shoppe by 14.8% in the first quarter. Vanguard Group Inc. now owns 2,186,549 shares of the specialty retailer’s stock worth $44,059,000 after buying an additional 282,598 shares in the last quarter. Olstein Capital Management L.P. boosted its stake in shares of Vitamin Shoppe by 22.9% in the first quarter. Olstein Capital Management L.P. now owns 802,133 shares of the specialty retailer’s stock worth $16,163,000 after buying an additional 149,338 shares in the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC boosted its stake in shares of Vitamin Shoppe by 6.8% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,910,081 shares of the specialty retailer’s stock worth $38,488,000 after buying an additional 122,445 shares in the last quarter. 96.86% of the stock is currently owned by hedge funds and other institutional investors.
VSI has been the topic of a number of research reports. Zacks Investment Research downgraded Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Wednesday, May 3rd. Morgan Stanley raised Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price target for the company in a research note on Thursday, May 11th. Gabelli cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. Barclays PLC reaffirmed an “equal weight” rating and set a $13.00 target price (down previously from $24.00) on shares of Vitamin Shoppe in a research report on Sunday, May 14th. Finally, ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Four research analysts have rated the stock with a sell rating and seven have given a hold rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $14.38.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Stock Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related stocks with our FREE daily email newsletter.